Jet lag-induced circadian disruption elevates glioma risk by altering molecular profiles in distinct brain regions
Yong Zhang1, Wanling Zheng2,3, Rufei Dai1
1Department of Neurosurgery, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, Jiangsu, China.
Purpose:
To investigate the mechanism underlying chronic jet lag (CJL)-induced circadian disruption stimulating glioma-related gene expression across distinct brain regions, and to examine the regulatory role of core clock genes in modulating neural oncogenic susceptibility.
Methods:
This experiment was initiated with the establishment of an animal model of CJL (6-h light-cycle advances every 2 days for 10 or 30 days) in wild-type and clock gene-deficient mice (Bmal1-/-, Per1/2-/-, and Cry1/2-/-). Then, tissues harvested from six neural regions (i.e., hippocampus, prefrontal cortex, striatum, hypothalamus, raphe nuclei, and nucleus accumbens) were subjected to tissue-specific qPCR profiling of cancer-related genes (C-MYC, MDM-2, GADD45A, and p53). Additionally, bioinformatics analyses (DAVID, ConsensusPathDB) was employed to identify pathway interactions, with statistical validation using ANOVA and t-tests.
Results:
CJL induced brain region-specific dysregulation of oncogenic pathways, with marked activation of oncogenes (C-MYC↑, and MDM-2↑) in hypothalamic and striatal regions, while suppression of tumor suppressors (GADD45A↓, and p53↓) in hippocampal and cortical regions. Clock gene mutations amplified these effects, particularly in Bmal1-/- mice, indicating core clock components as critical modulators of neural oncogenesis. Meanwhile, sex-dependent differences emerged in cerebellar tumor suppressor responses to CJL. Besides, pathway analysis revealed circadian-glioma crosstalk through p53-mediated apoptosis and cell cycle regulation.
Conclusion:
Chronic circadian disruption acts as a brain region-specific oncogenic stressor, driving transcriptional reprogramming of cancer pathways in a clock gene-dependent manner. Mechanistically, our study may establish a relationship of circadian dysfunction with glioma risk, underscoring the necessity for sex-stratified chronotherapeutic approaches in neuro-oncology.
More Related Videos
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
09:17Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
